Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department

Background: Proton pump inhibitors (PPIs) have been shown in cell culture to kill Trichomonas vaginalis (TV) at lower half maximal inhibitory concentration values than metronidazole (Flagyl), the most common medication used to treat the infection. However, there have been no previous clinical invest...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of sexually transmitted diseases and AIDS 2017-01, Vol.38 (1), p.60-64
Main Authors: Sheele, Johnathan, Morris, Nathan, Byars, Donald, Counselman, Frank
Format: Article
Language:English
Subjects:
Cell culture
Chlamydia
Datasets
Drugs
Ethanol
FDA approval
Gonorrhea
Infections
Medical records
Parasites
Parasitic diseases
Premature labor
Sexually transmitted diseases
STD
Studies
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Proton pump inhibitors (PPIs) have been shown in cell culture to kill Trichomonas vaginalis (TV) at lower half maximal inhibitory concentration values than metronidazole (Flagyl), the most common medication used to treat the infection. However, there have been no previous clinical investigations to determine if PPIs are associated with reduced risk for TV. Materials and Methods: We examined the records of female patients who received testing in the emergency department for TV, Neisseria gonorrhoea (GC), and Chlamydia trachomatis (CT) between 2010 and 2014 at two academic medical centers to determine if PPI and histamine type 2 receptor antagonist (H2RA) drugs were associated with TV and GC/CT infections. Results: We found that H2RAs were associated with an increased likelihood for TV (odds ratio [OR]: 2.0, P
ISSN:2589-0557
2589-0565
DOI:10.4103/0253-7184.203438